Announced
Financials
Tags
Denmark
Pharmaceuticals
Majority
pharmaceutical company
Acquisition
Friendly
Pending
Tender Offer
Public
Single Bidder
Private Equity
Synopsis
Asahi Kasei Group, a global Japanese chemical company, offered to acquire Veloxis, a Danish pharmaceutical company, for $1.3bn. The offer price represents a premium of 6% compared to the 30-trading day volume weighted average share price of the target. "Veloxis has created signicant value for all shareholders which we believe is reflected in this tender offer. We are excited about the commitment Asahi Kasei has made to the continued development of Veloxis while also maintaining the Company’s focus on improving the lives of transplant patients," Michael Heffernan, Veloxis Chairman of the Board of Directors.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.